InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (156 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
156
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Booth Bruce, Chairman & CEO. Director active across 5 companies, notably Kymera Therapeutics, Inc.. Cumulatively, 162 reports have been recorded. Breakdown: 0 buy · 156 sells. Total volume traded: €57.1m. History available since 11 August 2021. The latest transaction was filed on 21 October 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations162 total
28,296 sharesCommon StockSEC:0001451612-26-000018:0
231,007 sharesCommon StockSEC:0001451612-26-000018:1
32,624 sharesCommon StockSEC:0001451612-26-000018:2
11,277 sharesCommon StockSEC:0001451612-26-000018:3
10,366 sharesCommon StockSEC:0001451612-26-000018:4
555 sharesCommon StockSEC:0001451612-26-000018:5
14,913 sharesCommon StockSEC:0001451612-26-000018:6
27,951 sharesCommon StockSEC:0001451612-26-000018:7
6,821 sharesCommon StockSEC:0001451612-26-000018:8
12,181 sharesCommon StockSEC:0001451612-26-000018:9
22,046 sharesCommon StockSEC:0001451612-26-000018:10
12,390 sharesCommon StockSEC:0001451612-26-000018:11
3,958 sharesCommon StockSEC:0001451612-26-000018:12
32,402 sharesCommon StockSEC:0001451612-26-000018:13
4,562 sharesCommon StockSEC:0001451612-26-000018:14
1,579 sharesCommon StockSEC:0001451612-26-000018:15
1,442 sharesCommon StockSEC:0001451612-26-000018:16
78 sharesCommon StockSEC:0001451612-26-000018:17
2,083 sharesCommon StockSEC:0001451612-26-000018:18
3,896 sharesCommon StockSEC:0001451612-26-000018:19
952 sharesCommon StockSEC:0001451612-26-000018:20
1,701 sharesCommon StockSEC:0001451612-26-000018:21
3,069 sharesCommon StockSEC:0001451612-26-000018:22
1,729 sharesCommon StockSEC:0001451612-26-000018:23
5,471 sharesCommon StockSEC:0001451612-26-000018:24
25 of 162 declarations
About Booth Bruce
Daniel J. Starck is the Chief Executive Officer and Executive Vice President, President Patient Direct at Apria, Inc. and Owens & Minor Inc. In these roles, he oversees the operations and strategy of the company, focusing on improving patient care. Daniel is responsible for the strategic direction and growth of both companies, playing a key role in innovation and operational efficiency.
